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Abstract 
Objectives: 1) Evaluate Ohio pharmacists’ awareness about Centers for Medicare and Medicaid Service’s (CMS) Medication Drug Plan 
(MDP) Star Ratings, 2) identify gaps in knowledge about CMS MDP Star Ratings, and 3) determine interest in continuing education (CE) 
opportunities with CMS PDP Star Ratings. 
Methods: A cross-sectional, online survey was conducted in February 2015. The 16-question, pilot-tested survey targeted licensed 
pharmacists in Ohio practicing in the ambulatory care or community setting. Respondents were surveyed on their self-assessed and 
actual knowledge on CMS MDP Star Ratings. Respondent’s interest in and preferred source and delivery of CE were evaluated. Data 
were collected in aggregate; descriptive statistics, ANOVA and chi-square tests were used to characterize and evaluate data. Responses 
were summarized for all 16 questions using frequencies and percentages. 
Results: Of 13,235 licensed Ohio pharmacists, 913 pharmacists completed the survey (6.9% response rate). 454 (49.7%) respondents 
were eligible to complete the survey based on practice setting and of those, 390 (85.9%) were aware of CMS’s MDP Star Ratings. 
Respondents’ self-assessment of their knowledge regarding CMS Star Ratings aligned with their actual knowledge as defined by 
performance on three multi-statement knowledge-based assessments. Significant differences existed between self-assessed knowledge 
groups in their ability to answer greater than 50% of questions correctly (p < .001). The majority of respondents (81.2%) indicated 
interest in receiving further education on CMS Star Ratings. 
Conclusions: Survey respondents are aware of CMS MDP Star Ratings, yet few indicated high knowledge levels on the topic. Gaps in 
knowledge were identified in development and utilization of the rating system, identifying quality measures, and sources utilized to 
measure achievement of ratings. Respondents indicated interest in opportunities to improve knowledge on the subject and would 
prefer education provided by their employer with a live presentation. 
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Introduction 
The pharmacist’s role in healthcare is shifting as evidenced by 
legislation across the country expanding pharmacist practice in 
states such as Washington, Oregon, California, and Ohio. 1-5 
Opportunities such as collaborative practice agreements, 
medication therapy management, naloxone dispensing 
without a prescription, and medication synchronization 
provide pharmacists with the tools to offer a wide range of 
patient care. While this expanded scope of practice provides 
opportunities for all pharmacists, community and ambulatory 
care pharmacists in particular are uniquely qualified and 
positioned to improve patient outcomes and related quality 
measures through improving medication adherence, 
conducting patient safety interventions, and remedying gaps  
and optimizing medication regimens. These types of 
interventions and related outcomes align with the quality 
measures rated in The Centers for Medicare and Medicaid 
Services’ (CMS) Medication Drug Plans (MDP) Star Ratings.  
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The CMS Star Rating System was implemented in 2007 in an 
attempt to define, measure, and reward quality healthcare 
achieved by Medication Drug Plans (MDP) such as Medicare 
Advantage and prescription drug plans.6 Initially, the CMS Star 
Rating System was a tool for patients to identify high 
performing plans; however, in 2012, under the Affordable Care 
Act, CMS began utilizing the Star Ratings System as a tool to 
reward high performing plans with financial and non-financial 
incentives such as quality bonus payments and expanded 
enrollment benefits respectively.6  
 
Plans are rated from one to five, with five as the highest rating, 
on 32 Medicare Part C and 15 Medicare Part D quality 
measures.  Each quality measure is single to triple weighted 
with a triple-weighted measure counting three times that of a 
single weighted measure in the determination of the overall 
star rating. 7 In 2016, four of the nine triple-weighted quality 
measures were related to medication therapy.  Moreover, five 
of the fifteen Part D quality measures were related to 
medication adherence and management.7 The expected 
difference in quality bonus payments by moving from a three-
star plan to a five-star plan is $16 per member, per month.8 
This is a significant fiscal opportunity for health plans. Thus, 
they are now evaluating  pharmacies with the same quality 
metrics used by CMS to determine which pharmacies to 
include in their network.9 This places pharmacists, particularly 
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those in outpatient settings like ambulatory and community, 
in an important position to provide care to patients to improve 
plan ratings.8,10 A study conducted by Teeter et al found that 
pharmacists who were more knowledgeable on CMS Star 
Ratings offered more services and initiatives to impact those 
ratings.11 Pharmacists can increase their value to their 
employers, patients, and to their own pharmacy by 
implementing services and initiatives to target these quality 
metrics.  
 
Currently, there are few studies evaluating ambulatory care or 
community pharmacists’ awareness or knowledge of the CMS 
Star Rating System.11 The purpose of this study is to evaluate 
Ohio community and ambulatory care pharmacists’ awareness 
of the CMS Star Rating System, identify gaps in knowledge 
about CMS Star Ratings, and determine interest in continuing 
professional development opportunities related to CMS Star 
Ratings. 
 
Methods 
This descriptive, cross-sectional study surveyed Ohio 
community and ambulatory care pharmacists. Email addresses 
for all licensed pharmacists in Ohio were obtained from the 
Ohio State Board of Pharmacy. The initial email invitation was 
sent in February 2015 via QualtricsTM, an online survey tool. A 
reminder email was sent out two weeks later; the survey 
closed after four weeks. Eligible respondents included licensed 
Ohio pharmacists who identified as practicing in the 
community or ambulatory care setting.   
 
The survey consisted of 16 multiple choice questions gathering 
respondent demographics, assessing awareness and 
knowledge of the rating system, and interest in continuing 
education opportunities. If the respondent identified as 
practicing in the ambulatory or community pharmacy settings, 
s/he was asked about awareness of CMS Star Ratings. 
Respondents aware of the system were directed to self-assess 
their own knowledge on the topic. Respondent’s knowledge 
on the topic was then assessed by three questions, which each 
consisted of multi-statement “yes/true”, “no/false”, or “do not 
know” assessments. The first knowledge-based question 
consisted of seven statements related to identifying quality 
measures.  The second knowledge-based question consisted of 
five statements related to identifying mechanisms to measure 
achievement of CMS Star Ratings.  The third knowledge-based 
question consisted of five statements related to the 
development and utilization of CMS Star Ratings. This 
categorization of the statements affiliated with the three 
knowledge-based questions was determined by investigators 
through proposal, review, discussion, and consensus. Interest 
in continuing education was assessed by a “yes/no” multiple 
choice question. Respondents interested in continuing 
education were directed to Likert-scale questions assessing 
preferred sources and delivery method of continuing 
education. To ascertain respondents’ specific gaps in 
knowledge, each statement within the three knowledge-based 
assessments was examined separately. An initial cut point of 
50% was chosen by researchers as an initial representative 
marker for assessing knowledge and identifying gaps.  If 
greater than 50% of respondents correctly answered that 
statement, it was considered to be understood.  If less than 
50% of respondents correctly answered that statement, it was 
considered a knowledge gap. 
 
The survey was created by student researchers, faculty, and a 
Post-Graduate Year One (PGY1) pharmacy practice resident 
with experience in community pharmacy service development 
and provision. Knowledge-based questions were based on the 
CMS Star Ratings associated directly with medication use and 
may be relevant to ambulatory or community pharmacists. 
The survey was piloted by pharmacy practice residents in the 
community and ambulatory care settings to determine clarity 
of questions and time to complete the survey. Data from the 
pilot was not included in the results. This study was 
determined exempt from review by The Ohio State University 
Institutional Review Board. 
 
In order to ensure only eligible respondents’ awareness and 
knowledge was collected, those who identified as currently 
practicing in a setting other than community or ambulatory 
care were directed to the end of the survey. Those 
respondents who denied awareness of CMS Star Ratings 
skipped the knowledge-based questions; their actual 
knowledge was not measured. Respondents were not required 
to respond to any question, so response rates varied 
throughout the survey. 
 
Responses were summarized for all 16 survey questions using 
frequencies and percentages. The primary focus included the 
three knowledge-based questions which aimed to assess 
respondents’ actual knowledge on the rating system. These 
three questions were individually summarized and an overall 
percentage correct was determined for each question by 
calculating the proportion of “correct” statements for each 
question.  Finally, the grand overall percent correct was 
calculated over all three questions. Differences in the overall 
percent correct were assessed between knowledge groups 
using analysis of variance (ANOVA). The overall percent correct 
was categorized into <50% and >50% and proportions were 
compared between knowledge groups using chi-square tests. 
All analyses were performed using SAS/STAT software, Version 
9.4 of the SAS System for Windows (SAS Institute Inc., Cary, 
NC). 
 
Results 
A total of 13,235 surveys were sent to licensed Ohio 
pharmacists and 913 (6.9%) responded. Of those, 454 (49.7%) 
met eligibility criteria based on the pharmacy setting reported 
as community or ambulatory care.  Most often, respondents 
identified as a Staff Pharmacist (45.6%) or Pharmacy Manager 
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(32.1%) (Table 1). 444 respondents answered the question, 
“Have you heard of Centers for Medicare and Medicaid Five-
Star Quality Rating System (CMS Star Ratings)?” and 381/444 
(83.9%) reported they were aware of CMS Star Ratings.  Of 
these, place of employment (54.3%) and professional 
pharmacy organizations (21.1%) were ranked as the most 
common sites for exposure to CMS Star Ratings. 
 
The 381 respondents who reported awareness of CMS Star 
Ratings self-assessed their level of knowledge related to CMS 
Star Ratings (very knowledgeable, knowledgeable, not 
knowledgeable) and answered three multi-statement, 
knowledge-based assessments to objectively measure their 
actual knowledge (Figure 1).  Of the 381 eligible respondents, 
335 (87.9%) completed the self-assessment question; 15 
(4.5%) reported to be “very knowledgeable”, 190 (56.7%) 
reported to be “knowledgeable”, and 130 (38.8%) reported to 
be “not at all knowledgeable” about CMS Star Ratings. 
Knowledge-based assessment performance was compared to 
self-reported knowledge within each group and between 
groups.  Those who reported to be “very knowledgeable” 
correctly answered a higher mean percent of the multi-
statement knowledge-based assessments compared to those 
who reported to be either “knowledgeable” (p=0.017) “not at 
all knowledgeable” (p=0.017).  Similarly, those who reported 
to be “knowledgeable” also correctly answered a higher 
percent of the multi-statement knowledge-based assessments 
compared to those who were “not at all knowledgeable” 
(p<0.001). More respondents with higher self-reported 
knowledge could answer at least 50% of the multi-statement 
knowledge-based assessments correctly (p< 0.001). 
 
Overall, pharmacists correctly identified true quality measures 
of MDPs, but incorrectly identified non-measures as measures.  
Respondents more often correctly identified the mechanisms 
to measure achievement of CMS Star Ratings, but were 
frequently incorrect in recognizing how CMS Star Ratings are 
developed and utilized. (Figure 1)   
 
For the three multi-statement knowledge-based assessments, 
respondents accurately reported the following statements 
regarding CMS Star Ratings as true: 1) Star Ratings is part of 
CMS’ effort to define, measure, and reward quality healthcare; 
2) quality measures of MDPs include percentage of patients 
who are diabetic and on an Angiotensin Converting Enzyme-
Inhibitor/Angiotensin II Receptor Blocker, who are adherent to 
hypertension medications, and who are greater than 65 years 
old on high risk medications; 3) insurance companies may 
choose to exclude a pharmacy from its network for poor 
ratings; 4) plans that receive a 4 or 5 star rating may receive 
quality bonus payments from CMS while those who receive < 
3 stars for 2 consecutive years may be dropped from CMS; 5) 
4 stars is not the highest rating a plan can receive.  
 
Knowledge gaps were identified as respondents incorrectly 
reported the following to be true: 1) pharmacies receive an 
overall rating; 2) quality measures of MDPs include percentage 
of patients who have heart failure and are on a beta blocker 
and who are adherent to injectable diabetic medications. 
More than 50% of respondents “did not know” that the 
Consumer Assessment of Healthcare Providers and System 
(CAHPS) and the Healthcare Effectiveness Data and 
Information Set (HEDIS) surveys are used by CMS to rate 
insurance plans or that plans can receive half ratings. 
 
Finally, interest in continuing education on the topic was 
assessed324 (81.2%) of 399 respondents were interested in 
receiving continuing education (CE) about CMS Star Ratings.  
Among those interested, desired sources for provision of 
continuing education included the respondent’s employer 
(40.6%), pharmacy organizations (30.4%), a national CE 
Distributor (19.7%) and colleges of pharmacy (9.3%). Preferred 
delivery methods included live presentation (31.0%), written 
materials with self-study online (29.2%) and hard copy 
(22.9%), interactive presentation (9.2%), and a webinar (7.7%).  
Approximately 140 respondents indicated they would pay for 
an hour of CE; 63 (45.0%) respondents were willing to pay $1-
10 per hour for CE.  
 
Discussion 
This study demonstrated Ohio community and ambulatory 
care pharmacists responding to our survey were aware of CMS 
Star Ratings and could accurately self-assess their knowledge 
level on the subject. Large gaps in knowledge were identified, 
especially related to CMS Star Ratings development and 
utilization. In order for pharmacists to fully engage with CMS 
Star Ratings, they must have adequate knowledge of the Star 
Ratings and how to impact them.  
 
A previous study by Teeter et al evaluated community 
pharmacy owners’ current awareness, knowledge, and 
attitudes towards CMS Star Ratings, their measurement, as 
well as initiatives being offered to improve patient care. Their 
results corroborated our results that while community 
pharmacy owners are aware of star ratings, they lack 
knowledge on how the ratings are calculated and used to 
evaluate performance.11 This is an area of opportunity to 
educate pharmacists on how CMS Star Ratings apply to the 
pharmacy profession and overall, how pharmacies can 
collaborate to with MDPs and other healthcare providers to 
improve plan ratings. Demers et al described activities that can 
contribute to improving CMS Star Ratings for insurance plans. 
In community and ambulatory care practice environments, 
pharmacists can provide immunizations and medication 
therapy management services, engage in medication 
reconciliation and health screenings, and monitor and improve 
medication adherence.17  
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A 2013 stakeholder discussion of the challenges and 
opportunities associated with the CMS Star Rating System may 
also provide guidance on the role of community pharmacists 
in improving CMS Star Ratings. Findings from this stakeholder 
meeting show that community pharmacists are in an ideal 
position to help MDPs overcome barriers to medication safety 
and adherence due to their frequent patient interactions, 
relationships with patients and prescribers, their adjudication 
and prescription data, and their utilization of technology to 
communicate with patients.10 By impacting CMS Star Ratings 
through optimizing medication regimens and adherence, 
pharmacists have the potential to improve the health of 
patients, thus, reducing health care costs. 
 
Over half of the respondents in our study expressed desire for 
either live or online continuing education on CMS Star Ratings. 
Community pharmacies, state pharmacy organizations, and 
colleges of pharmacy were identified as main sources of 
exposure to CMS Star Ratings, and they would likely serve as 
the most useful venues for hosting continuing education 
opportunities. While the Pharmacy Quality Alliance and other 
national professional organizations have tackled this 
educational topic18-20, the results or this survey question how 
many practicing pharmacists at the local level are accessing 
these training opportunities. Education for practicing 
pharmacists that is easily accessible, affordable, and offered in 
a variety of formats at the local level is an area of opportunity 
for academic institutions and professional organizations. 
 
To our knowledge, this is the first study evaluating community 
and ambulatory care pharmacists’ knowledge of CMS Star 
Ratings. Currently, publications about pharmacy and CMS Star 
Ratings are limited with regard to pharmacy engagement and 
primarily illustrate pay-for-performance models, the key 
players in these models, and their roles.9- 12  There is only one 
published study demonstrating the potential impact of 
pharmacist interventions on plan ratings. 16 This study, the 
Pennsylvania Project, evaluated the impact of pharmacy-
based interventions on the adherence to five chronic 
medications. For patients taking statins and oral diabetic 
medications, pharmacists involved in the project saved $20 
and $28 per member, per month, respectively. This translated 
into $1.4 million dollars in annual savings. Additionally, if the 
plan solely contracted with the intervention group, their CMS 
Star Rating would have increased by one star.16 With few 
published studies demonstrating models to impact CMS Star 
Ratings and the lack of pharmacist knowledge about CMS Star 
Ratings found in our study, there exists a need and opportunity 
for pharmacist education as well as evaluation of pharmacist 
engagement with and impact on CMS Star Ratings.  
 
Limitations 
There are some limitations to this study. The survey had an 
overall low response rate, which could have been due the 
email delivery format and/or due to the study design targeting 
a specific ambulatory and community care pharmacist 
population. Currently licensed pharmacists may not have the 
most up-to-date contact information listed with the State 
Board of Pharmacy; thus, all eligible pharmacists may not have 
received the survey. Additionally, the total number of 
pharmacists practicing in a community or ambulatory care 
setting in Ohio is unknown, so the true response rate cannot 
be calculated. Due to the exploratory nature of this descriptive 
survey, the authors selected 50% as a representative marker 
for assessing knowledge and identifying gaps. This cut point is 
not a validated threshold for knowledge could be a limitation. 
The low response rate and concerns about response bias do 
not allow these results to be generalized to the entire state of 
Ohio pharmacist population.  
 
Conclusion 
 Respondents in Ohio demonstrated awareness of CMS Star 
Ratings; however, gaps in knowledge and interest in 
continuing education on the topic were identified.  CMS Star 
Ratings and the associated incentives provide a tremendous 
opportunity for pharmacists to help improve ratings related to 
medication use for health plans. In order for pharmacists to 
engage with aiding plans’ goals of achieving improved star 
ratings, it is critical to be aware of and knowledgeable about 
the CMS Star Ratings System first. As the Star Ratings System 
continues to have a larger impact on CMS medication drug 
plans, this study highlights results from practicing pharmacists 
in Ohio a need for structured pharmacist education 
opportunities (i.e. CE). These identified gaps in Ohio are 
relevant to colleges of pharmacy, employers, and 
organizations to consider local educational efforts; they also 
stimulate questions regarding level of knowledge and 
awareness of pharmacists in other states and encourage 
future studies on the interventions and impacts pharmacists 
can make through engaging with CMS Star Ratings. 
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Table 1. Respondent Demographics 
 
Characteristic n (%) Respondents 
 
Practice Setting 
 
Community Pharmacy  
Chain 
Independent 
Grocery/Supermarket 
Mass Merchandisera 
Ambulatory Care Clinic 
 
n = 454  
 
423 (93.2%) 
175 (38.5%) 
116 (25.6%) 
94 (20.7%) 
38 (8.4%) 
31 (6.8%) 
 
Current Title 
 
Staff Pharmacist 
Pharmacy Manager 
Clinical Pharmacist 
Owner 
Other 
District or Regional Manager or Coordinator 
Clinical Coordinator 
 
n = 448 
 
204 (45.6%) 
144 (32.1%) 
33 (7.4%) 
32 (7.1%) 
17 (3.8%) 
10 (2.2%) 
8 (1.8%) 
 
Years Practiced  
 
> 30 years 
1-4 years 
20-29 years 
5-9 years 
15-19 years 
10-14 years 
 
n = 446  
 
115 (25.8%) 
84 (18.8%) 
82 (18.4%) 
69 (15.5%) 
49 (11.0%) 
47 (10.5%) 
a Mass merchandiser describes pharmacies that offer products beyond groceries,  
such as Costco, Walmart, etc. 
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Figure 1. Respondent Performance on Knowledge of CMS Star Ratings (n=335) 
 
 
a T/F and Y/N in parenthesis next to each question indicate the correct response. 
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